2:
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO.
Eur J Cancer. 2008 Jan;44(1):73-83. Epub 2007 Nov 26.
PMID: 18035533 [PubMed - indexed for MEDLINE]
Related Articles
11:
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Thürlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A; International Breast Cancer Study Group.
J Clin Oncol. 2008 Jun 20;26(18):3006-14. Epub 2008 May 5.
PMID: 18458044 [PubMed - indexed for MEDLINE]
Related Articles
13:
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H, Buccholz TA, Hortobagyi GN.
J Clin Oncol. 2005 Jan 1;23(1):41-8.
PMID: 15625359 [PubMed - indexed for MEDLINE]
Related Articles
15:
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.
Wenzel C, Bartsch R, Hussian D, Pluschnig U, Altorjai G, Zielinski CC, Lang A, Haid A, Jakesz R, Gnant M, Steger GG.
Breast Cancer Res Treat. 2007 Jul;104(1):109-14. Epub 2006 Oct 24.
PMID: 17061042 [PubMed - indexed for MEDLINE]
Related Articles